Should I buy Corpay (CPAY) stock or is it too late?

Corpay · Financials · price $399

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Cantor Fitzgerald — 76% of its targets hit on this sector (21 calls tested). It aims for $480 (+20 %), call made on August 11, 2026, maturing on August 11, 2027 (64 d ago).

The 7 reliable analysts $470+18 %

The 2 other firms $471+18 %

How to read it: the 7 reliable firms are not filtered by optimism — 7 aim above the price, 0 below, hence their $470 median. “The 2 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Corpay

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Barclays	60 %	-0.7 %	5	$400 +0%
Keefe, Bruyette & Woods	20 %	-2.6 %	5	$470 +18%

In short — Should you invest in Corpay? Is it too late, still worth it? Analysts are fairly positive (78% buy, median target $470, i.e. +18%), and the most reliable on CPAY targets even higher. But it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

78% of analysts rate it a buy (Buy consensus, 9 ratings) — a sign of market conviction.
Median price target $470, i.e. +18% from the current price ($399).
The most reliable firm on CPAY, JP Morgan (100% hit rate, 3 scored calls), targets $470 (call made on August 6, 2026, maturing on August 6, 2027) (+18%) in its most recent call, and $350 (call made on November 6, 2025, maturing on November 6, 2026) (-12%) in the one coming due soonest.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 9 ratings, 2 are neutral.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
No dividend: your return depends only on price appreciation.

The analyst consensus on CPAY

Median target $470 (+18%) · 9 ratings · Buy consensus

Strong Buy00%

Buy778%

Hold222%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Corpay now?

We won't decide for you. The facts: 78% of analysts rate it a buy, median target $470 (+18%), and JP Morgan (most reliable on CPAY, 100%) targets $470. Weigh that against valuation (P/E ~24). This is not personalized advice.

Is it too late to invest in Corpay?

Not according to analysts: the median target ($470) is still +18% above the current price ($399) (most reliable on CPAY: JP Morgan, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Corpay still worth investing in?

It depends on the gap between the price ($399) and its estimated value: analysts target $470 on median (+18%), with 78% buys (most reliable on CPAY: JP Morgan, 100%). Cross-check with their real reliability on CPAY and the cautions above. Information, not advice.

What's the main risk in buying CPAY?

The consensus is not unanimous: of 9 ratings, 2 are neutral.

→ Go deeper: the full Corpay profile (consensus, analyst reliability, price target, performance).